Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 244

Results For "NIT"

6388 News Found

Delhi becomes 35th state/UT to implement AB PM-JAY
Policy | April 07, 2025

Delhi becomes 35th state/UT to implement AB PM-JAY

Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme


Plex Research partners With Ginkgo Bioworks on AI powered drug discovery to identify novel disease mechanisms
News | April 07, 2025

Plex Research partners With Ginkgo Bioworks on AI powered drug discovery to identify novel disease mechanisms

Findings likely to generate hypotheses about potential new uses of drugs


Alife expands personal care portfolio with Gondhoraj & Neem soap in West Bengal
News | April 07, 2025

Alife expands personal care portfolio with Gondhoraj & Neem soap in West Bengal

The unique soap-fusion of Gondhoraj lime and neem provides a refreshing skin-friendly experience


Fluor to provide EPCM services for pharmaceutical facility in Indiana
News | April 07, 2025

Fluor to provide EPCM services for pharmaceutical facility in Indiana

This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202


Sumitomo Chemical establishes a CRO for Oligonucleotide CDMO business in US
News | April 07, 2025

Sumitomo Chemical establishes a CRO for Oligonucleotide CDMO business in US

Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013


Lupin acquires UK-based Renascience Pharma for £12.3 million
News | April 04, 2025

Lupin acquires UK-based Renascience Pharma for £12.3 million

The portfolio includes branded injectable cephalosporines for infectious diseases


Gland Pharma receives approval for Acetaminophen Injection
Drug Approval | April 04, 2025

Gland Pharma receives approval for Acetaminophen Injection

The company expects to launch this product through its marketing partner in the near future


Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025
News | April 04, 2025

Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025

New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle AD study


AstraZeneca’s Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancer
Drug Approval | April 04, 2025

AstraZeneca’s Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancer

Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone